Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
SARS-CoV-2 stability similar to original SARS virus.
The trial will enroll healthy volunteers to test the vaccine’s safety and ability to trigger an immune response.
But it comes with deep cuts to Medicare, Medicaid, Social Security, cancer funds and other health and science programs.
The National Cancer Institute stands to lose more than $500 million, and cancer prevention programs are at risk.
The American Cancer Society sets the record straight.
Using such products increased their risk by 60% and 30%, respectively.
Last year, the federal agency invested nearly $300 million in the search for HIV cure therapies.
The study of a contraceptive gel for men is ongoing.
Federal researchers describe two paths to a vaccine—and one of them uses high-tech computers to design a vaccine candidate!
The trial will investigate whether injections of long-acting cabotegravir and rilpivirine yield a superior rate of viral suppression.
A $3.5 million grant to the University of Illinois at Chicago will help researchers find out.
Can data from more than 1 million Americans accelerate research and medical breakthroughs that benefit everyone?
Can loads more research dollars stop Alzheimer’s disease by 2025?
A doctor and breast cancer survivor works with the All of Us Research Program, which aims to customize medical treatment for individuals.
A new campaign and program aim to boost awareness of and access to post-exposure prophylaxis.
U.S. activists unveil a national action plan to #BreakThePatent. It points out that taxpayers funded the research behind Truvada as PrEP.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.